VASO-OCCLUSIVE CRISIS
Clinical trials for VASO-OCCLUSIVE CRISIS explained in plain language.
Never miss a new study
Get alerted when new VASO-OCCLUSIVE CRISIS trials appear
Sign up with your email to follow new studies for VASO-OCCLUSIVE CRISIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Sickle cell patients continue experimental drug to monitor Long-Term safety
Disease control TerminatedThis study aimed to check the long-term safety of inclacumab, an experimental drug for sickle cell disease. It was for people who had already received the drug in a previous Pfizer trial. Participants received the drug every 12 weeks, and researchers tracked any side effects and …
Matched conditions: VASO-OCCLUSIVE CRISIS
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Breathing machine trial aims to shield kids from sickle Cell's worst lung attack
Prevention TerminatedThis study tested if a gentle breathing machine (non-invasive ventilation) could better prevent a dangerous lung problem called acute chest syndrome in children hospitalized for sickle cell pain crises. It compared the machine to the standard treatment of deep-breathing exercises…
Matched conditions: VASO-OCCLUSIVE CRISIS
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Mar 23, 2026 15:15 UTC